Probi's report for the fourth quarter 2020 will be published on Tuesday, 9 February at 8.00 a.m. CET.
In conjunction with this, analysts, investors and media are invited to an audiocast telephone conference on the same day at 10.00 a.m., where CEO Tom Rönnlund and CFO Henrik Lundkvist will present and comment on the report. The presentation and presentation material can be obtained via www.probi.com or https://tv.streamfabriken.com/probi-q4-2020
The presentation can also be followed via a telephone conference on the following telephone number:
Sweden: +46 8 50 55 83 53
UK: +44 33 33 00 92 67
US: +1 83 35 26 83 47
After the presentation, conference participants will be able to ask questions. Questions can also be asked via the audiocast.
An on-demand version of the presentation will be available at the address given above following the presentation.
For further information, please contact:
Henrik Lundkvist, CFO, Probi,
Phone +46 46 286 89 41, E-mail: henrik.lundkvist@probi.com
ABOUT PROBI
Probi[®] is a global company focused exclusively on researching, manufacturing, and delivering probiotics for supplements and functional food. The company is an expert in managing stable, live bacteria from research through every stage of the manufacturing process and are dedicated to making the health-enhancing benefits of probiotics available to people everywhere. Since the company was founded in 1991 at Lund University in Sweden, Probi has expanded its operations to more than 40 markets and holds more than 400 patents worldwide. Probi had sales of SEK 626 m in 2019. Probi's shares are listed on Nasdaq Stockholm, Mid-cap. and there were around 4,000 shareholders on December 31, 2019.